Addressing Questions Regarding Long-Term Treatment with a TPRV1 Agonist for Painful DPN of the Feet

Host: David M. Simpson, MD <br> Guest: Serge Perrot, MD, PhD <br> <p>Dive into the data from an international trial evaluating the long-term safety and tolerability of a treatment option for painful diabetic peripheral neuropathy of the feet with Dr. David M. Simpson, a Professor of Neurology at Icahn School of Medicine at Mount Sinai, and Professor Serge Perrot, a Professor of Clinical Pharmacology at Paris Descartes University.</p> <p><strong>Find the full <span style="text-decoration: underline;"><a href="https://www.qutenza.com/pdfs/Qutenza_Prescribing_Information.pdf">Prescribing Information here</a></span>.</strong></p> <p>QUTENZA^® is a registered trademark of Averitas Pharma, Inc.<br />© 2021 Averitas Pharma, Inc. All rights reserved.<br />M-QZA-US-01-21-0073 June 2021</p>